Order Article Reprints

Diaz-Martinez J, Kotzker W, Mendoza-Hernandez MA, Gadh RS, Hernandez-Fuentes GA, Bañuelos A, Guzmán-Esquivel J, Hong A, Delgado-Enciso OG, Geyer-Roberts E, et al. Analysis of Survival Modification by Furosemide Use in a Cohort of Hospitalized COVID-19 Patients with Severe or Critical Disease in Mexico: Due to Its Chemical Structure, Furosemide Is More than Just a Diuretic. Pharmaceutics. 2024; 16(7):920. https://doi.org/10.3390/pharmaceutics16070920

Diaz-Martinez, Janet, Wayne Kotzker, Martha A. Mendoza-Hernandez, Rajdeep S. Gadh, Gustavo A. Hernandez-Fuentes, Andrew Bañuelos, José Guzmán-Esquivel, Angelina Hong, Osiris G. Delgado-Enciso, Elizabeth Geyer-Roberts, and et al. 2024. "Analysis of Survival Modification by Furosemide Use in a Cohort of Hospitalized COVID-19 Patients with Severe or Critical Disease in Mexico: Due to Its Chemical Structure, Furosemide Is More than Just a Diuretic" Pharmaceutics 16, no. 7: 920. https://doi.org/10.3390/pharmaceutics16070920

Diaz-Martinez, J., Kotzker, W., Mendoza-Hernandez, M. A., Gadh, R. S., Hernandez-Fuentes, G. A., Bañuelos, A., Guzmán-Esquivel, J., Hong, A., Delgado-Enciso, O. G., Geyer-Roberts, E., Martinez-Fierro, M. L., Rodriguez-Sanchez, I. P., Garza-Veloz, I., Canseco-Ávila, L. M., & Delgado-Enciso, I. (2024). Analysis of Survival Modification by Furosemide Use in a Cohort of Hospitalized COVID-19 Patients with Severe or Critical Disease in Mexico: Due to Its Chemical Structure, Furosemide Is More than Just a Diuretic. Pharmaceutics, 16(7), 920. https://doi.org/10.3390/pharmaceutics16070920